A team has identified an antibody that appears to block infection by all dominant variants of the virus that causes COVID-19, including omicron. Their discovery could lead to more potent vaccines and new antibody-based treatments.
More research and oversight are needed before making permanent a pandemic policy that allows hospitals to treat acutely ill patients in their homes, according to new Cornell research.
Severe COVID-19 infection triggers changes that affect gene expression in immune system stem cells, causing alterations in the body’s immune response, according to a new study by Weill Cornell Medicine and Jackson Laboratory investigators.
A protein that prepares DNA for replication also prevents the replication process from running out of control, according to a new study by Weill Cornell Medicine researchers.
With the six-month, $1 million grant, Weill Cornell Medicine researchers will assess how countries have been monitoring and reporting COVID-19 infections and outcomes.
A new vaccine distribution model expands the concept of vaccine coverage to include vaccinated person-days, which prioritize both the number of people vaccinated and the speed of getting shots into arms.
Members of the Weill Cornell Medicine Class of 2027 received their short white coats on Aug. 15 during the annual White Coat Ceremony, officially marking the beginning of their medical education.
Acinetobacter pittii (A. pittii), a type of bacteria, is evolving to become more resistant to antibiotics and is finding ways to survive in the harsh environment of the International Space Station, according to new research led by Weill Cornell Medicine scientists.